AI-supported mammography increases breast cancer detection, reduces interval cancers, and substantially lowers radiologist workload versus standard double reading.
Key Details
- 1MASAI trial assigned 105,915 women to AI-assisted or double-reading groups in screening.
- 2AI-assisted mammography decreased interval cancer rate by 12% (1.55 vs. 1.76 per 1,000 women).
- 3Sensitivity was higher for AI (80.5%) compared to double reading (73.8%), with specificity unchanged (98.5% both groups).
- 4AI support resulted in a 44% reduction in screen-reading workload and a 29% increase in cancer detection without increasing false positives.
- 5Improvements were consistent across age and breast density, but not for in-situ cancers.
- 6The study highlights significant relevance amid a shortage of breast radiologists.
Why It Matters
These large-scale findings support integrating AI into breast cancer screening workflows for both higher detection rates and better efficiency, critical as radiology faces workforce challenges. Evidence from randomized trials will influence adoption, reimbursement, and future research.
Source
AuntMinnie
Related News
•Radiology Business
AI Analyzes Mammograms to Assess Post-Surgery Breast Cancer Recurrence Risk
A new AI tool predicts likelihood of breast cancer recurrence after surgery using pre-operative mammograms.
•Radiology Business
Landmark Study: AI-Supported Mammography Outperforms Standard Screening
A large Swedish trial finds that AI-assisted mammography detects more breast cancers and reduces future diagnosis rates compared to standard practices.
•Radiology Business
Patient Perceptions of AI in Mammography Differ Across Healthcare Settings
A survey of over 900 women reveals substantial variation in acceptance and expectations of AI in mammography depending on healthcare setting and demographics.